Evaluation of body composition parameters in patients with psoriasis

International Journal of Dermatology

Volumn 53, Issue 12, 2014, Pages 1468-1473

  Engin, Burhan ^a   Kutlubay, Zekayi ^a   Yardimci, Gürkan ^a   Vehid, Hayriye Ertem ^a   Ambarcioğlu, Pinar ^a   Serdaroğlu, Server ^a   Tüzün, Yalçin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CYCLOSPORIN A; INFLIXIMAB; METHOTREXATE; RETINOID;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; BONE MASS; FAT FREE MASS; FAT MASS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; PHOTOCHEMOTHERAPY; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; RETROSPECTIVE STUDY; SYSTEMIC THERAPY; TOTAL BODY WATER; BODY MASS; OBESITY; PATHOPHYSIOLOGY; PSORIASIS; RISK FACTOR;

ADIPOSITY; ADULT; BODY COMPOSITION; BODY MASS INDEX; FEMALE; HUMANS; MALE; OBESITY; PSORIASIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84913584156     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12171     Document Type: Article

References (21)

1. Pedreira PG, Pinheiro MM, Szejnfeld VL. Bone mineral density and body composition in post-menopausal women with psoriasis and psoriatic arthritis. Arthritis Res Ther 2011; 13: R16.
2. Kim N, Thrash B, Menter A. Comorbidities in psoriasis patients. Semin Cutan Med Surg 2010; 29: 10-15.
3. Alsufyani MA, Golant AK, Lebwohl M. Psoriasis and the metabolic syndrome. Dermatol Ther 2010; 23: 137-143.
4. Takahashi H, Iizuka H. Psoriasis and metabolic syndrome. J Dermatol 2012; 39: 212-218.
5. Serdaroğlu S, Parlak AH, Engin B, et al. The prevalence of psoriasis and vitiligo in a rural area in Turkey. J Turk Acad Dermatol 2012; 6: 1-5.
6. Cohen AD, Gilutz H, Henkin Y, et al. Psoriasis and the metabolic syndrome. Acta Derm Venereol 2007; 87: 506-509.
7. Al-Mutairi N, Al-Farag S, Al-Mutairi A, et al. Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol 2010; 37: 146-155.
8. Mebazaa A, El Asmi M, Zidi W, et al. Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants. J Eur Acad Dermatol Venereol 2011; 25: 705-709.
9. Bongiorno MR, Doukaki S, Rizzo D, et al. The prevalence of obesity in patients with moderate to severe psoriasis in Sicily populations. J Eur Acad Dermatol Venereol 2010; 24: 92-93.
10. Lindegård B. Diseases associated with psoriasis in a general population of 159, 200 middle-aged, urban, native Swedes. Dermatologica 1986; 172: 298-304.
11. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-1534.
12. Augustin M, Reich K, Glaeske G, et al. Comorbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm Venereol 2010; 90: 147-151.
13. Zhang C, Zhu KJ, Zheng HF, et al. The effect of overweight and obesity on psoriasis patients in Chinese Han population: a hospital-based study. J Eur Acad Dermatol Venereol 2011; 25: 87-91.
14. Balci A, Balci DD, Yonden Z, et al. Increased amount of visceral fat in patients with psoriasis contributes to metabolic syndrome. Dermatology 2010; 220: 32-37.
15. Sommer DM, Jenisch S, Suchan M, et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298: 321-328.
16. Bhole VM, Choi HK, Burns LC, et al. Differences in body mass index among individuals with PsA, psoriasis RA and the general population. Rheumatology 2012; 51: 552-556.
17. Renzo LD, Saraceno R, Schipani C, et al. Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment. Dermatol Ther 2011; 24: 446-451.
18. Saraceno R, Schipani C, Mazzotta A, et al. Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis. Pharmacol Res 2008; 57: 290-295.
19. Florin V, Cottencin AC, Delaporte E, et al. Body weight increment in patients treated with infliximab for plaque psoriasis. J Eur Acad Dermatol Venereol 2013; 27: e186-190.
20. Boehncke WH, Boehncke S, Tobin AM, et al. The "psoriatic march": a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 2011; 20: 303-307.
21. Gottlieb AB, Chao C, Dann F. Psoriasis comorbidities. J Dermatolog Treat 2008; 19: 5-21.